| Muda uliopangwa | Bei Iliyotabiriwa | Zamani | Kihistoria | Maarifa |
|---|---|---|---|---|
| Kesho | $39.29 ▲ +1.33% | Jana | $38.56 ▼ -0.56% | Tomorrow's Travere Therapeutics Inc. Common Stock (TVTX) setup is anchored to $38.78 and targets $39.29 (+1.33%). The near-term read is upside; watch $39.94 / $37.62 because daily realized volatility is about 6.84%. |
Tomorrow's Travere Therapeutics Inc. Common Stock (TVTX) setup is anchored to $38.78 and targets $39.29 (+1.33%). The near-term read is upside; watch $39.94 / $37.62 because daily realized volatility is about 6.84%. | ||||
| Wiki | $40.38 ▲ +4.12% | Wiki Iliyopita | $38.11 ▼ -1.73% | The 7-day Travere Therapeutics Inc. Common Stock model moves from $38.11 to $40.38 (+4.12%). It gives upside momentum context for this stock, so breaks around $39.94 / $37.62 matter more than a single tick. |
The 7-day Travere Therapeutics Inc. Common Stock model moves from $38.11 to $40.38 (+4.12%). It gives upside momentum context for this stock, so breaks around $39.94 / $37.62 matter more than a single tick. | ||||
| Mwezi | $42.19 ▲ +8.79% | Mwezi uliopita | $37.35 ▼ -3.69% | The 1-month Travere Therapeutics Inc. Common Stock target is $42.19 (+8.79%), compared with the live reference near $38.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Travere Therapeutics Inc. Common Stock target is $42.19 (+8.79%), compared with the live reference near $38.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Mwaka | $44.90 ▲ +15.77% | Mwaka jana | $36.21 ▼ -6.62% | The 1-year Travere Therapeutics Inc. Common Stock scenario points to $44.90 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Travere Therapeutics Inc. Common Stock scenario points to $44.90 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| Miaka 5 | $51.25 ▲ +32.14% | Miaka 5 Iliyopita | $33.54 ▼ -13.50% | The 5-year Travere Therapeutics Inc. Common Stock view is $51.25 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Travere Therapeutics Inc. Common Stock view is $51.25 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Kiashiria | Thamani | Mawimbi |
|---|---|---|
| Price | $38.78 | Mid |
| Daily Change | -3.75% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $38.78 | Daily Change | -3.75% |
| Market Cap | $3.58B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.